Perkins Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Perkins Investment Management's PFE Position: Q1 2017 in Review
Perkins Investment Management increased its Pfizer (PFE) stake by 17% in Q1 2017, buying an estimated $10.5M and bringing the position to 2,281,213 shares worth $74M. The position accounts for 0.92% of the portfolio, ranked #39.
Perkins Investment Management first reported a position in PFE in Q2 2013 and has held it in 16 quarters since. 2,075 funds tracked by Wall St. Rank hold PFE as of Q1 2017.
- Perkins Investment Management held 2,281,213 shares of Pfizer worth $74M as of Q1 2017.
- Perkins Investment Management bought 332,227 Pfizer shares in Q1 2017, an estimated $10.5M.
- Pfizer made up 0.92% of Perkins Investment Management's portfolio in Q1 2017, its #39 holding.
- Perkins Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 16 quarters since.
- 2,075 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.
Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.